Key facts
- ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for AVANOS MEDICAL, INC. Common Stock - $0.01 Par Value (AVNS).
- Disclosed ownership: 4.3%.
- Date of event: 31 Mar 2026.
ARMISTICE CAPITAL, LLC - 31 Mar 2026 SCHEDULE 13G/A Report for AVANOS MEDICAL, INC. Common Stock - $0.01 Par Value (AVNS)
- Filing Manager
- ARMISTICE CAPITAL, LLC
- Reporting Manager
- Armistice Capital, LLC
- Symbol
- AVNS
- Shares outstanding
- 46,511,628 shares
- Disclosed Ownership
- 2,000,000 shares
- Ownership
- 4.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 11:06:44 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 17 Feb 2026
- SEC
- View on sec.gov
Key filing fact
ARMISTICE CAPITAL, LLC disclosed 4.3% ownership in AVANOS MEDICAL, INC. Common Stock - $0.01 Par Value (AVNS) on 31 Mar 2026.
Change
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 15 May 2026, 11:06.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 4.3% | 2,000,000 | 0 | 2,000,000 | /s/ Steven Boyd | Steven Boyd - Managing Member | |
| Steven Boyd | 4.3% | 2,000,000 | 0 | 2,000,000 | /s/ Steven Boyd | Steven Boyd |
CIK / CUSIP context first